Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Jeffrey D. Bloss
Prognostic Factors for Response to Cisplatin-Based Chemotherapy in Advanced Cervical Carcinoma: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Related publications
A Phase I Study of Concurrent Weekly Topotecan and Cisplatin Chemotherapy With Whole Pelvic Radiation Therapy in Locally Advanced Cervical Cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase I/Ii Study of Extended Field Radiation Therapy With Concomitant Paclitaxel and Cisplatin Chemotherapy in Patients With Cervical Carcinoma Metastatic to the Para-Aortic Lymph Nodes: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Radiation Therapy With or Without Weekly Cisplatin for Bulky Stage 1B Cervical Carcinoma: Follow-Up of a Gynecologic Oncology Group Trial
American Journal of Obstetrics and Gynecology
Gynecology
Obstetrics
Outcomes of Non-High Grade Serous Carcinoma After Neoadjuvant Chemotherapy for Advanced-Stage Ovarian Cancer: A Korean Gynecologic Oncology Group Study (OV 1708)
BMC Cancer
Cancer Research
Oncology
Genetics
Prognostic Relevance of Carbonic Anhydrase-Ix in High-Risk, Early-Stage Cervical Cancer: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
A Phase I Study of Paclitaxel, Topotecan, Cisplatin and Filgrastim in Patients With Newly Diagnosed Advanced Ovarian Epithelial Malignancies: A Gynecologic Oncology Group Study
Gynecologic Oncology
Gynecology
Oncology
Obstetrics
Gynecologic Oncology Group Study 229C: Personal Reflection
Proceedings in Obstetrics and Gynecology
Size of Cervical Lesion in Locally Advanced Carcinoma Cervix and Response to Neoadjuvant Chemotherapy
International Journal of Reproduction, Contraception, Obstetrics and Gynecology
Phase II Study of Neoadjuvant Chemotherapy With Irinotecan Hydrochloride and Nedaplatin Followed by Radical Hysterectomy for Bulky Stage Ib2 to IIb, Cervical Squamous Cell Carcinoma: Japanese Gynecologic Oncology Group Study (JGOG 1065)
Oncology Reports
Medicine
Cancer Research
Oncology